Bioglass: A New Era in Modern Dentistry

Shruti Singh; Amit Patil; Sheetal Mali; Himmat Jaiswal

doi:10.1055/s-0042-1742356

European Journal of General Dentistry, Inhaltsverzeichnis

CC BY 4.0 · European Journal of General Dentistry 2022; 11(01): 001-006
DOI: 10.1055/s-0042-1742356

Review Article

Bioglass: A New Era in Modern Dentistry

Shruti Singh

¹Department of Conservative and Endodontics, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, Maharashtra, India

,

Amit Patil

¹Department of Conservative and Endodontics, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, Maharashtra, India

,

Sheetal Mali

¹Department of Conservative and Endodontics, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, Maharashtra, India

,

Himmat Jaiswal

¹Department of Conservative and Endodontics, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, Maharashtra, India

› Institutsangaben

Abstract

The function of biomaterials has been to replace infected or injured tissues. The first used biomaterials were bioinert, thus minimizing formation of scar tissue at the interface with host tissues. Bioglass was discovered in 1969. Larry Hench developed Bioglass 45S5, which was the earliest synthetic substance that was bonded chemically with bone. In recent researches it has appeared that Bioglass bonds with bone more readily than other bioceramics; it also indicated that the osteogenic properties are due to stimulation of osteoprogenitor cells by the dissolution products formed from Bioglass. Bioglass is chemically calcium sodium phosphosilicate, which is capable of forming an active chemical bond with the tissues. Bioglass is particularly biocompatible which, when placed in body cavity or on reacting with body stimulating factors, induces hydroxyapatite formation. This paper reviews Bioglass as a material of modern dentistry and its various applications in modern dentistry. It also discusses its composition, methods of preparation, and mechanism of action, along with its advantages and disadvantages.

Keywords

Bioglass - hydroxyapatite - broad-spectrum antimicrobial - bioactive glass - sol-gel technique

Volltext

Referenzen

References
1 Hench LL. The story of bioglass. J Mater Sci Mater Med 2006; 17 (11) 967-978
2 Ferreira MM, Brito AF, Brazete D. et al; Experimental Study in Rats. Doping β-TCP as a strategy for enhancing the regenerative potential of composite β-TCP-alkali-free bioactive glass bone grafts. Materials (Basel) 2018; 12 (01) 4
3 Hench LL, Splinter RJ, Allen WC, Greenlee TK. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res Symp 1971; 5 (06) 117-141
4 Skallevold HE, Rokaya D, Khurshid Z, Zafar MS. Bioactive glass applications in dentistry. Int J Mol Sci 2019; 20 (23) 5960
5 Rodriguez O, Alhalawani A, Arshad S, Towler MR. Rapidly-dissolving silver-containing bioactive glasses for cariostatic applications. J Funct Biomater 2018; 9 (02) 28
6 Jones J, Gentleman E, Polak J. Bioactive glass scaffolds for bone regeneration. Elements. 2007; 3: 393-399
7 Hoppe A, Jokic B, Janackovic D. et al. Cobalt-releasing 1393 bioactive glass-derived scaffolds for bone tissue engineering applications. ACS Appl Mater Interfaces 2014; 6 (04) 2865-2877
8 Groh D, Döhler F, Brauer DS. Bioactive glasses with improved processing. Part 1. Thermal properties, ion release and apatite formation. Acta Biomater 2014; 10 (10) 4465-4473
9 El-Meliegy E, Noort R. Glasses and Glass Ceramics for Medical Applications. New York, NY: Springer; 2012
10 Chen QZ, Xu JL, Yu LG, Fang XY, Khor KA. Spark plasma sintering of sol–gel derived 45S5 Bioglass^®-ceramics: mechanical properties and biocompatibility evaluation. Mater Sci Eng C 2012; 32: 494-502
11 Prasad S, Vyas VK, Ershad M, Pyare R. Crystallization and mechanical properties of (45S5-HA) biocomposite for biomedical implantation. Ceram Silik 2017; 61: 378-384
12 Wu C, Fan W, Gelinsky M. et al. Bioactive SrO-SiO2 glass with well-ordered mesopores: characterization, physiochemistry and biological properties. Acta Biomater 2011; 7 (04) 1797-1806
13 Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater 2013; 9 (01) 4457-4486
14 Hill RG, Brauer DS. Predicting the bioactivity of glasses using the network connectivity or split network models. J Non-Cryst Solids 2011; 357: 3884-3887
15 Stoor P, Söderling E, Salonen JI. Antibacterial effects of a bioactive glass paste on oral microorganisms. Acta Odontol Scand 1998; 56 (03) 161-165
16 Lindfors NC, Hyvönen P, Nyyssönen M. et al. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone 2010; 47 (02) 212-218
17 Galarraga-Vinueza ME, Mesquita-Guimarães J, Magini RS, Souza JC, Fredel MC, Boccaccini AR. Anti-biofilm properties of bioactive glasses embedding organic active compounds. J Biomed Mater Res A 2017; 105 (02) 672-679
18 Salonen JI, Arjasmaa M, Tuominen U, Behbehani MJ, Zaatar E. Bioactive glass in dentistry. J Minim Interv Dent 2009; 2: 208-2018
19 Sarin S, Rekhi A. Bioactive glass: a potential next generation biomaterial. SRM J Res Dent Sci 2016; 7: 27-32
20 Lanza R, Langer R, Vacanti J. Principles of Tissue Engineering. 3rd ed.. Cambridge, MA: Academic Press; 2011. ISBN 9780080548845
21 Lovelace TB, Mellonig JT, Meffert RM, Jones AA, Nummikoski PV, Cochran DL. Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans. J Periodontol 1998; 69 (09) 1027-1035
22 Peltola MJ, Aitasalo KM, Suonpää JT, Yli-Urpo A, Laippala PJ, Forsback AP. Frontal sinus and skull bone defect obliteration with three synthetic bioactive materials. A comparative study. J Biomed Mater Res B Appl Biomater 2003; 66 (01) 364-372
23 Tadjoedin ES, de Lange GL, Lyaruu DM, Kuiper L, Burger EH. High concentrations of bioactive glass material (BioGran) vs. autogenous bone for sinus floor elevation. Clin Oral Implants Res 2002; 13 (04) 428-436
24 Hench L, Hench JW, Greenspan D. Bioglass: a short history and bibliography. J. Aust. Ceram Soc. 2004; 40: 1-42
25 Fujikura K, Karpukhina N, Kasuga T, Brauer D, Hill R, Law R. Influence of strontium substitution on structure and crystallisation of Bioglass^® 45S5. J Mater Chem 2012; 22: 7395-7402
26 Skallevold HE, Rokaya D, Khurshid Z, Zafar MS. Bioactive glass applications in dentistry. Int J Mol Sci 2019; 20 (23) 5960
27 Pereira-Cenci T, Cenci MS, Fedorowicz Z, Marchesan MA. Antibacterial agents in composite restorations for the prevention of dental caries. Cochrane Database Syst Rev 2009; (03) CD007819
28 Profeta AC. Dentine bonding agents comprising calcium-silicates to support proactive dental care: origins, development and future. Dent Mater J 2014; 33 (04) 443-452
29 Tezvergil-Mutluay A, Seseogullari-Dirihan R, Feitosa VP, Cama G, Brauer DS, Sauro S. Effects of composites containing bioactive glasses on demineralized dentin. J Dent Res 2017; 96 (09) 999-1005
30 Khvostenko D, Mitchell JC, Hilton TJ, Ferracane JL, Kruzic JJ. Mechanical performance of novel bioactive glass containing dental restorative composites. Dent Mater 2013; 29 (11) 1139-1148
31 Yli-Urpo H, Närhi T, Söderling E. Antimicrobial effects of glass ionomer cements containing bioactive glass (S53P4) on oral micro-organisms in vitro. Acta Odontol Scand 2003; 61 (04) 241-246
32 Prabhakar AR, Paul M J, Basappa N. Comparative evaluation of the remineralizing effects and surface micro hardness of glass ionomer cements containing bioactive glass (S53P4): an in vitro study. Int J Clin Pediatr Dent 2010; 3 (02) 69-77
33 Siqueira Jr JF, Rôças IN, Souto R, de Uzeda M, Colombo AP. Actinomyces species, streptococci, and Enterococcus faecalis in primary root canal infections. J Endod 2002; 28 (03) 168-172
34 Siqueira Jr JF. Aetiology of root canal treatment failure: why well-treated teeth can fail. Int Endod J 2001; 34 (01) 1-10
35 Krithikadatta J, Indira R, Dorothykalyani AL. Disinfection of dentinal tubules with 2% chlorhexidine, 2% metronidazole, bioactive glass when compared with calcium hydroxide as intracanal medicaments. J Endod 2007; 33 (12) 1473-1476
36 Love RM. Enterococcus faecalis–a mechanism for its role in endodontic failure. Int Endod J 2001; 34 (05) 399-405
37 Chong BS, Pitt Ford TR. The role of intracanal medication in root canal treatment. Int Endod J 1992; 25 (02) 97-106
38 Oguntebi BR. Dentine tubule infection and endodontic therapy implications. Int Endod J 1994; 27 (04) 218-222
39 Safavi KE, Spangberg LS, Langeland K. Root canal dentinal tubule disinfection. J Endod 1990; 16 (05) 207-210
40 Thomas MV, Puleo DA, Al-Sabbagh M. Bioactive glass three decades on. J Long Term Eff Med Implants 2005; 15 (06) 585-597
41 Zehnder M, Söderling E, Salonen J, Waltimo T. Preliminary evaluation of bioactive glass S53P4 as an endodontic medication in vitro. J Endod 2004; 30 (04) 220-224
42 Goel A, Sinha A, Khandeparker RV, Mehrotra R, Vashisth P, Garg A. Bioactive glass S53P4 versus chlorhexidine gluconate as intracanal medicament in primary teeth: an in-vivo study using polymerase chain reaction analysis. J Int Oral Health 2015; 7 (08) 65-69
43 Idon PI, Esan TA, Bamise CT. Oral health-related quality of life in patients presenting with dentine hypersensitivity: a randomized controlled study of treatment effect. Eur J Gen Dent 2017; 6: 99-105
44 Tirapelli C, Panzeri H, Lara EH, Soares RG, Peitl O, Zanotto ED. The effect of a novel crystallised bioactive glass-ceramic powder on dentine hypersensitivity: a long-term clinical study. J Oral Rehabil 2011; 38 (04) 253-262
45 Chen L, Al-Bayatee S, Khurshid Z, Shavandi A, Brunton P, Ratnayake J. Hydroxyapatite in oral care products-a review. Materials (Basel) 2021; 14 (17) 4865
46 Anthoney D, Zahid S, Khalid H. et al. Effectiveness of thymoquinone and fluoridated bioactive glass/nano-oxide contained dentifrices on abrasion and dentine tubules occlusion: an ex vivo study. Eur J Dent 2020; 14 (01) 45-54
47 de Morais RC, Silveira RE, Chinelatti M, Geraldeli S, de Carvalho Panzeri Pires-de-Souza F. Bond strength of adhesive systems to sound and demineralized dentin treated with bioactive glass ceramic suspension. Clin Oral Investig 2018; 22 (05) 1923-1931
48 Hirschfeld L, Wasserman B. A long-term survey of tooth loss in 600 treated periodontal patients. J Periodontol 1978; 49 (05) 225-237
49 Profeta AC, Prucher GM. Bioactive-glass in periodontal surgery and implant dentistry. Dent Mater J 2015; 34 (05) 559-571
50 Müller F, Wahl G, Fuhr K. Age-related satisfaction with complete dentures, desire for improvement and attitudes to implant treatment. Gerodontology 1994; 11 (01) 7-12
51 Albrektsson T, Brånemark PI, Hansson HA, Lindström J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981; 52 (02) 155-170
52 Talreja PS, Gayathri GV, Mehta DS. Treatment of an early failing implant by guided bone regeneration using resorbable collagen membrane and bioactive glass. J Indian Soc Periodontol 2013; 17 (01) 131-136
53 Mistry S, Roy R, Kundu B. et al. Clinical outcome of hydroxyapatite coated, bioactive glass coated, and machined Ti6Al4V threaded dental implant in human jaws: a short-term comparative study. Implant Dent 2016; 25 (02) 252-260
54 Mendes AC, Restrepo M, Bussaneli D, Zuanon AC. Use of casein amorphous calcium phosphate (CPP-ACP) on white-spot lesions: randomised clinical trial. Oral Health Prev Dent 2018; 16 (01) 27-31
55 Brauer DS, Karpukhina N, O'Donnell MD, Law RV, Hill RG. Fluoride-containing bioactive glasses: effect of glass design and structure on degradation, pH and apatite formation in simulated body fluid. Acta Biomater 2010; 6 (08) 3275-3282
56 Farooq I, Majeed A, Alshwaimi E, Almas K. Efficacy of a novel fluoride containing bioactive glass based dentifrice in remineralizing artificially induced demineralization in human enamel. Fluoride 2018; 52: 447-455